Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 817

1.

Optimal radiotherapy for prostate cancer: predictions for conventional external beam, IMRT, and brachytherapy from radiobiologic models.

King CR, DiPetrillo TA, Wazer DE.

Int J Radiat Oncol Biol Phys. 2000 Jan 1;46(1):165-72.

PMID:
10656389
2.
3.

Dose escalation in permanent brachytherapy for prostate cancer: dosimetric and biological considerations.

Li XA, Wang JZ, Stewart RD, DiBiase SJ.

Phys Med Biol. 2003 Sep 7;48(17):2753-65.

PMID:
14516099
4.

Impact of tumor repopulation on radiotherapy planning.

Wang JZ, Li XA.

Int J Radiat Oncol Biol Phys. 2005 Jan 1;61(1):220-7.

PMID:
15629615
5.

Radiation dose escalation for localized prostate cancer: intensity-modulated radiotherapy versus permanent transperineal brachytherapy.

Wong WW, Vora SA, Schild SE, Ezzell GA, Andrews PE, Ferrigni RG, Swanson SK.

Cancer. 2009 Dec 1;115(23):5596-606. doi: 10.1002/cncr.24558.

7.

Dosimetry and radiobiologic model comparison of IMRT and 3D conformal radiotherapy in treatment of carcinoma of the prostate.

Luxton G, Hancock SL, Boyer AL.

Int J Radiat Oncol Biol Phys. 2004 May 1;59(1):267-84.

PMID:
15093924
8.
9.

The low alpha/beta ratio for prostate cancer: what does the clinical outcome of HDR brachytherapy tell us?

Wang JZ, Li XA, Yu CX, DiBiase SJ.

Int J Radiat Oncol Biol Phys. 2003 Nov 15;57(4):1101-8.

PMID:
14575842
10.

Methodology for biologically-based treatment planning for combined low-dose-rate (permanent implant) and high-dose-rate (fractionated) treatment of prostate cancer.

Zaider M, Zelefsky MJ, Cohen GN, Chui CS, Yorke ED, Ben-Porat L, Happersett L.

Int J Radiat Oncol Biol Phys. 2005 Mar 1;61(3):702-13.

PMID:
15708248
11.

Simultaneous integrated intensity-modulated radiotherapy boost for locally advanced gynecological cancer: radiobiological and dosimetric considerations.

Guerrero M, Li XA, Ma L, Linder J, Deyoung C, Erickson B.

Int J Radiat Oncol Biol Phys. 2005 Jul 1;62(3):933-9.

PMID:
15936580
12.

Dosimetric advantages of IMRT simultaneous integrated boost for high-risk prostate cancer.

Li XA, Wang JZ, Jursinic PA, Lawton CA, Wang D.

Int J Radiat Oncol Biol Phys. 2005 Mar 15;61(4):1251-7.

PMID:
15752907
13.

Fitting tumor control probability models to biopsy outcome after three-dimensional conformal radiation therapy of prostate cancer: pitfalls in deducing radiobiologic parameters for tumors from clinical data.

Levegr√ľn S, Jackson A, Zelefsky MJ, Skwarchuk MW, Venkatraman ES, Schlegel W, Fuks Z, Leibel SA, Ling CC.

Int J Radiat Oncol Biol Phys. 2001 Nov 15;51(4):1064-80.

PMID:
11704332
14.

Impact of prolonged fraction delivery times on tumor control: a note of caution for intensity-modulated radiation therapy (IMRT).

Wang JZ, Li XA, D'Souza WD, Stewart RD.

Int J Radiat Oncol Biol Phys. 2003 Oct 1;57(2):543-52.

PMID:
12957268
15.

Conformal irradiation of concave-shaped PTVs in the treatment of prostate cancer by simple 1D intensity-modulated beams.

Fiorino C, Broggi S, Corletto D, Cattaneo GM, Calandrino R.

Radiother Oncol. 2000 Apr;55(1):49-58.

PMID:
10788688
16.
17.

Comparison of biologically equivalent dose-volume parameters for the treatment of prostate cancer with concomitant boost IMRT versus IMRT combined with brachytherapy.

Pieters BR, van de Kamer JB, van Herten YR, van Wieringen N, D'Olieslager GM, van der Heide UA, Koning CC.

Radiother Oncol. 2008 Jul;88(1):46-52. doi: 10.1016/j.radonc.2008.02.023. Epub 2008 Apr 2.

PMID:
18378028
18.
19.

Normal tissue dosimetric comparison between HDR prostate implant boost and conformal external beam radiotherapy boost: potential for dose escalation.

Hsu IC, Pickett B, Shinohara K, Krieg R, Roach M 3rd, Phillips T.

Int J Radiat Oncol Biol Phys. 2000 Mar 1;46(4):851-8.

PMID:
10705005
20.

Relationship between percent positive biopsies and biochemical outcome after permanent interstitial brachytherapy for clinically organ-confined carcinoma of the prostate gland.

Merrick GS, Butler WM, Galbreath RW, Lief JH, Adamovich E.

Int J Radiat Oncol Biol Phys. 2002 Mar 1;52(3):664-73.

PMID:
11849788

Supplemental Content

Support Center